FREE + EASY cancellation anytime for any reason
• Targets beta-3 adrenergic receptor pathways involved in fat breakdown
• Designed to support lipolysis without broader GH-related effects
• May help support body composition goals within a medical protocol
• Supports a targeted approach to fat metabolism
• Delivered per physician protocol under clinician supervision
AOD-9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone, isolating the segment believed to be responsible for GH's effects on fat metabolism. Unlike full-length growth hormone, AOD-9604 is designed to avoid significant impact on growth-related (IGF-1) or blood sugar pathways. The peptide is thought to interact with beta-3 adrenergic receptors on fat cells, stimulating lipolysis (the breakdown of stored fat) and inhibiting lipogenesis (the formation of new fat). EdgeRx offers AOD-9604 through a clinician-supervised peptide protocol, prescribed by licensed physicians for eligible patients as part of an individualized metabolic health plan.
No clinic visits. No phone tag. No waiting rooms.
Tell us about your goals, health history, and lifestyle. Licensed providers in all 50 states.
Your medication is made at a licensed pharmacy and shipped in plain packaging.
100% online visits and prescriptions. Made at licensed USA pharmacies. GLP-1, peptide, and hormone plans — prescribed by a doctor.
Shipping fees apply. All medications require a prescription from a licensed provider. Compounded medications are not FDA-approved.
